Latest broker research reports with buy, hold and sell recommendations along with share price targets forecast and upside.
Browse thousands of reports and search by company or broker.
Broker Research reports: All reports
for BSE SmallCap Select
Q2FY26 performance: MCX reported healthy result as expected with revenue of 374 crore, which increased by 31% YoY and was flattish sequentially. Average daily turnover (ADT) for futures segment has increased 55% YoY, 3% QoQ to 41,758 crore while options premium ADT has increased 25% YoY, 4% QoQ to 4096 crore. Sharp surge in price and volatility of gold as well as silver has boosted ADT growth. EBITDA grew 36% YoY and 1% QoQ at 243 crore. EBITDA margins...
NCC’s Q2FY26 reported a decline of 16% in revenues in Q2FY26 (vs I-Sec’s flat expectation). The execution was negatively impacted on account of low execution in existing order book for water segment (due to payment delays), prolonged monsoon and Co delay in start of work on order received during FY25 (40% of current order book).
MCX’s operating revenue came in at INR3.7b in 2QFY26, up 31% YoY (in line). For 1HFY26, revenue rose 44%, to INR7.5b. Total expenses jumped 23% YoY to INR1.3b, with staff costs up 37% YoY and other expenses up 17% YoY.
About the stock: Firstsource Solutions (FSL) provides business process services to BFSI, communication, media, tech and healthcare. FSL is a domain driven BPM services company which has 200+ global clients, including several Fortune-500...
Tata Chemicals (TTCH)’s 2QFY26 consolidated EBITDA declined 13% YoY, led by subdued performance in America (TCNA)/Africa (TCAHL)/Rallis, with EBITDA down 65%/58%/5% YoY due to a weak demand-supply scenario.
In-line result; robust volume growth trends continue: Indian Energy Exchange (IEX) reported 2QFY26 standalone revenue of INR1.5b and EBITDA of INR1.3b, both in line with estimates, supported by traded electricity volumes of 35.2BUs, which were also in line with expectations.
MGFL reported consol. PAT of INR2.2b in 2QFY26 (12% beat). NII declined ~16% YoY to ~INR13.8b (in line) and PPoP declined ~35% YoY to ~INR6.7b (in line). Operating expenses grew 6% YoY to ~INR7.4b (in line).
KFin Technologies (KFin) reported a 10% YoY growth in operating revenue to INR3.1b in 2QFY26 (in line). The revenue was driven by 10%/16%/33% YoY growth in domestic MF solutions/issuer solutions/international solutions segments.
After successfully strengthening its retail asset franchise during FY24–25, PNB Housing Finance (PNB HF) has shifted its focus towards enhancing profitability going ahead, and its highest quarterly (since FY21) RoE at >13% during Q2FY26 is a reflection of sustained improvement across financial parameters despite management transition.
Cyient reported Q2 FY26 results with DET revenue rising 3.3% QoQ and 4.5% YoY in rupee term, while EBIT margin improved 16 bps sequentially to 12.2%. Despite wage hikes and restructuring costs (200 bps impact), cost optimization offset the pressure. PAT stood at INR 137cr, down 16% QoQ. Transportation and Network & Infrastructure units grew 3.9% and 3.6% QoQ respectively, while the semiconductor business rebounded 12% QoQ, aided by strong order intake and a USD 100mn pipeline. DLM reported strong momentum in (with 130% YoY) order-intake and double-digit margins. The group expects to be EBIT-neutral in...
Kajaria Ceramics reported a broadly in-line Q2FY26 estimates on the revenue front, however profitability beat expectations on the back of sustained cost optimization measures. Consolidated revenue stood at Rs12bn, up just 1% YoY, reflecting continued weakness in tiles volume amid sluggish domestic demand. However, EBITDA rose sharply by 34% YoY to Rs2.1bn, aided by savings in packaging, procurement, and manpower costs, translating into a margin of 18% (+452bps). PAT came in at Rs1.3bn (+58% YoY). Management highlighted that short-term pain from the ongoing unification of sales and operations has...
New SIP registrations rose by 19% YoY, reaching 11.2 Mn in Q1 FY26. This growth profitable. Positioned for its next phase of growth, CAMS is focusing on disciplined cost management, scaling new business verticals, and leveraging key technology investments that are close to completion. The stock is currently trading at 36x 1-year forward P/E (5-year average:...
We met with the management team of Amara Raja to get an update on the business. OE demand has picked up after GST rate cuts, while replacement is yet to pick up, lead costs, excl. currency depreciation, remain stable QoQ.
We have revised our PAT estimates for FY26E/FY27E by +1.4/+2.3%, respectively, to factor in the higher EBITDA margin led by normalization on account of improved operating leverage, higher capacity utilization and led by cost optimization and efficiency improvement programs.
*over or under performance to benchmark index Dr Lal PathLabs Ltd (DLPL) provides diagnostic tests and services globally. As of December 2024, DLPL had 280 clinical laboratories, including a national reference lab...
